Quest Diagnostics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell DGX and other ETFs, options, and stocks.

About DGX

Quest Diagnostics, Inc. engages in the provision of diagnostic testing, information, and services. It operates through the Diagnostic Information Services (DIS) and All Other segments. 

CEO
James E. Davis
CEOJames E. Davis
Employees
56,000
Employees56,000
Headquarters
Secaucus, New Jersey
HeadquartersSecaucus, New Jersey
Founded
1967
Founded1967
Employees
56,000
Employees56,000

DGX Key Statistics

Market cap
23.01B
Market cap23.01B
Price-Earnings ratio
23.64
Price-Earnings ratio23.64
Dividend yield
1.55%
Dividend yield1.55%
Average volume
1.46M
Average volume1.46M
High today
$209.36
High today$209.36
Low today
$204.61
Low today$204.61
Open price
$207.50
Open price$207.50
Volume
1.32M
Volume1.32M
52 Week high
$213.20
52 Week high$213.20
52 Week low
$157.20
52 Week low$157.20

Stock Snapshot

With a market cap of 23.01B, Quest Diagnostics(DGX) trades at $207.00. The stock has a price-to-earnings ratio of 23.64 and currently yields dividends of 1.5%.

During the trading session on 2026-02-15, Quest Diagnostics(DGX) shares reached a daily high of $209.36 and a low of $204.61. At a current price of $207.00, the stock is +1.2% higher than the low and still -1.1% under the high.

Trading activity shows a volume of 1.32M, compared to an average daily volume of 1.46M.

Over the past 52 weeks, Quest Diagnostics(DGX) stock has traded between a high of $213.20 and a low of $157.20.

Over the past 52 weeks, Quest Diagnostics(DGX) stock has traded between a high of $213.20 and a low of $157.20.

DGX News

Simply Wall St 4h
Quest Diagnostics Is Up 8.5% After Strong 2026 Guidance And New Myeloma Test Launch - Has The Bull Case Changed?

In February 2026, Quest Diagnostics reported Q4 and full-year 2025 results with higher sales and earnings, issued 2026 guidance calling for US$11.70–US$11.82 bi...

Quest Diagnostics Is Up 8.5% After Strong 2026 Guidance And New Myeloma Test Launch - Has The Bull Case Changed?
Simply Wall St 3d
Quest Diagnostics MRD Blood Test May Support Growth In Higher Value Oncology

Quest Diagnostics (NYSE:DGX) has introduced a blood based minimal residual disease test for multiple myeloma that uses advanced flow cytometry. The company rep...

Quest Diagnostics MRD Blood Test May Support Growth In Higher Value Oncology
TipRanks 3d
Quest Diagnostics price target raised to $235 from $210 at Mizuho

Mizuho raised the firm’s price target on Quest Diagnostics (DGX) to $235 from $210 and keeps an Outperform rating on the shares. Published first on TheFly – th...

Analyst ratings

50%

of 18 ratings
Buy
50%
Hold
44.4%
Sell
5.6%

More DGX News

Nasdaq 4d
DGX Crosses Above Average Analyst Target

In recent trading, shares of Quest Diagnostics, Inc. (Symbol: DGX) have crossed above the average analyst 12-month target price of $188.71, changing hands for $...

DGX Crosses Above Average Analyst Target
Simply Wall St 4d
Quest Diagnostics 9% Net Margin Resurgence Challenges Long Term Earnings Decline Narrative

Advertisement Quest Diagnostics FY 2025 earnings in focus Quest Diagnostics (DGX) has put its FY 2025 numbers on the table with Q4 revenue of US$2.8 billion a...

Quest Diagnostics 9% Net Margin Resurgence Challenges Long Term Earnings Decline Narrative
TipRanks 5d
Quest Diagnostics Signals Growth Amid Margin Pressures

Quest Diagnostics ((DGX)) has held its Q4 earnings call. Read on for the main highlights of the call. Valentine's Day Sale - 70% Off Unlock hedge fund-level dat...

Benzinga 5d
Quest Diagnostics Stock Smashes 52-Week High On Strong Quarter, Dividend Hike

Quest Diagnostics Incorporated (NYSE:DGX) on Tuesday reported fourth-quarter adjusted earnings of $2.42 per share, beating the consensus of $2.36. The provider...

Quest Diagnostics Stock Smashes 52-Week High On Strong Quarter, Dividend Hike
The Motley Fool 5d
Quest Diagnostics Earnings Call Transcript

Image source: The Motley Fool. Tuesday, February 10, 2026 at 8:30 a.m. ET CALL PARTICIPANTS Chairman, Chief Executive Officer, and President — Jim Davis Execut...

Quest Diagnostics Earnings Call Transcript
TipRanks 5d
Quest Diagnostics Posts Strong 2025 Results, Boosts Shareholder Returns

Quest Diagnostics ( (DGX) ) has issued an announcement. On February 10, 2026, Quest Diagnostics reported that fourth-quarter 2025 revenue rose 7.1% year-on-yea...

Nasdaq 5d
Quest Diagnostics Guides FY26 Above Estimates; Boosts Dividend 7.5% - Update

(RTTNews) - While reporting financial results for the fourth quarter on Tuesday, diagnostic services firm Quest Diagnostics, Inc. (DGX) initiated its earnings,...

Quest Diagnostics Guides FY26 Above Estimates; Boosts Dividend 7.5% - Update

People also own

Based on the portfolios of people who own DGX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.